These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 17963460

  • 21. In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.
    Ozbek B, Otük G.
    Int J Antimicrob Agents; 2010 Aug; 36(2):191-2. PubMed ID: 20537868
    [No Abstract] [Full Text] [Related]

  • 22. In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.
    Tong W, Wang R, Chai D, Li Z, Pei F.
    Int J Antimicrob Agents; 2006 Nov; 28(5):454-6. PubMed ID: 16987639
    [Abstract] [Full Text] [Related]

  • 23. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW, Wang LS, Cheng YJ, Hsu GJ, Lu PL, Liu YC, Chen CM, Lee CM, Sun W, Jang TN, Chiang PC, Chuang YC, Lin HC, Shi ZY, Kung HC, Huang CH, Tsao SM, Lu CT, Liao CH, Hsueh PR.
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [Abstract] [Full Text] [Related]

  • 24. Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia.
    Garnacho-Montero J, Amaya-Villar R, Ferrándiz-Millón C, Díaz-Martín A, López-Sánchez JM, Gutiérrez-Pizarraya A.
    Expert Rev Anti Infect Ther; 2015 Jun; 13(6):769-77. PubMed ID: 25865094
    [Abstract] [Full Text] [Related]

  • 25. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects.
    Candel FJ, Calvo N, Head J, Sánchez A, Matesanz M, Culebras E, Barrientos A, Picazo J.
    Rev Esp Quimioter; 2010 Jun; 23(2):103-8. PubMed ID: 20559610
    [Abstract] [Full Text] [Related]

  • 26. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
    Montero A, Ariza J, Corbella X, Doménech A, Cabellos C, Ayats J, Tubau F, Borraz C, Gudiol F.
    J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
    [Abstract] [Full Text] [Related]

  • 27. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii.
    Urban C, Segal-Maurer S, Rahal JJ.
    Clin Infect Dis; 2003 May 15; 36(10):1268-74. PubMed ID: 12746772
    [Abstract] [Full Text] [Related]

  • 28. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
    Tan TY, Ng LS, Tan E, Huang G.
    J Antimicrob Chemother; 2007 Aug 15; 60(2):421-3. PubMed ID: 17540671
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY, Cheong HJ, Lee J, Sung AK, Kim WJ.
    Int J Antimicrob Agents; 2009 Jan 15; 33(1):33-9. PubMed ID: 18835761
    [Abstract] [Full Text] [Related]

  • 30. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
    Housman ST, Hagihara M, Nicolau DP, Kuti JL.
    J Antimicrob Chemother; 2013 Oct 15; 68(10):2296-304. PubMed ID: 23710070
    [Abstract] [Full Text] [Related]

  • 31. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases.
    Santimaleeworagun W, Wongpoowarak P, Chayakul P, Pattharachayakul S, Tansakul P, Garey KW.
    Southeast Asian J Trop Med Public Health; 2011 Jul 15; 42(4):890-900. PubMed ID: 22299471
    [Abstract] [Full Text] [Related]

  • 32. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H, Kus H, Arslan U, Tuncer I.
    Mikrobiyol Bul; 2014 Apr 15; 48(2):311-5. PubMed ID: 24819268
    [Abstract] [Full Text] [Related]

  • 33. Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians.
    Jain R, Danziger LH.
    Ann Pharmacother; 2004 Sep 15; 38(9):1449-59. PubMed ID: 15280512
    [Abstract] [Full Text] [Related]

  • 34. Treatment of pan-drug resistant Acinetobacter baumannii.
    Lee CM, Lim HK, Liu CP, Tseng HK.
    Scand J Infect Dis; 2005 Sep 15; 37(3):195-9. PubMed ID: 15849052
    [Abstract] [Full Text] [Related]

  • 35. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates.
    Deveci A, Coban AY, Acicbe O, Tanyel E, Yaman G, Durupinar B.
    J Chemother; 2012 Oct 15; 24(5):247-52. PubMed ID: 23182043
    [Abstract] [Full Text] [Related]

  • 36. Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007.
    Liang-Yu C, Kuo SC, Liu CY, Luo BS, Huang LJ, Lee YT, Chen CP, Chen TL, Fung CP.
    J Microbiol Immunol Infect; 2011 Oct 15; 44(5):358-63. PubMed ID: 21524973
    [Abstract] [Full Text] [Related]

  • 37. Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Chiang SR, Chuang YC, Tang HJ, Chen CC, Chen CH, Lee NY, Chou CH, Ko WC.
    Crit Care Med; 2009 Sep 15; 37(9):2590-5. PubMed ID: 19623044
    [Abstract] [Full Text] [Related]

  • 38. In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii.
    Plachouras D, Giamarellos-Bourboulis EJ, Kentepozidis N, Baziaka F, Karagianni V, Giamarellou H.
    Diagn Microbiol Infect Dis; 2007 Apr 15; 57(4):419-22. PubMed ID: 17188449
    [Abstract] [Full Text] [Related]

  • 39. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
    Punpanich W, Munsrichoom A, Srisarang S, Treeratweeraphong V.
    J Med Assoc Thai; 2011 Aug 15; 94 Suppl 3():S95-100. PubMed ID: 22043760
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
    Dinc G, Demiraslan H, Elmali F, Ahmed SS, Metan G, Alp E, Doganay M.
    Chemotherapy; 2013 Aug 15; 59(5):325-9. PubMed ID: 24525528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.